Zarmina Javed
Neurology · Coral Springs, FLNPI 1861001570
Payments from drug & device makers
Across 80 payments — averaging $25.68 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$334
- Biogen$246
- Takeda Pharmaceuticals U.S.A., Inc.$212
- Merz Pharmaceuticals, LLC$129
- AstraZeneca$123
- Novartis$113
- plus $898 from 20 others
What the payments were for
- Food & beverage$2,055100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 13 | $334 |
| Biogen | 7 | $246 |
| Takeda Pharmaceuticals U.S.A., Inc. | 12 | $212 |
| Merz Pharmaceuticals, LLC | 2 | $129 |
| AstraZeneca | 6 | $123 |
| Novartis | 6 | $113 |
| Biocodex, Inc. | 3 | $104 |
| Genentech, Inc. | 2 | $95 |
| EMD Serono, Inc. | 4 | $85 |
| Amgen | 2 | $62 |
| Sanofi | 2 | $59 |
| Argenx US, Inc. | 2 | $56 |
| Medtronic | 2 | $55 |
| TG Therapeutics, Inc. | 2 | $54 |
| Jazz Pharmaceuticals Inc. | 2 | $46 |
| Janssen Scientific Affairs, LLC | 1 | $42 |
| Neurocrine Biosciences, Inc. | 2 | $35 |
| Neurelis, Inc. | 2 | $34 |
| Genentech USA, Inc. | 1 | $24 |
| Catalyst Pharmaceuticals, Inc. | 1 | $24 |
| Acadia Pharmaceuticals Inc | 1 | $23 |
| Novo Nordisk | 1 | $21 |
| Eisai Inc. | 1 | $21 |
| Immedica Pharma US, Inc. | 1 | $21 |
| Lundbeck LLC | 1 | $20 |
| Acorda Therapeutics, Inc | 1 | $19 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$2,055 in reported general payments places this provider in the 45th percentile of 1,434 neurology providers in Florida.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Gabapentin | 12 | $166 |
Paid to pharmacies, not to this prescriber.
Other neurology in Coral Springs
- Mark GoldsteinAtlantis$36.1M
- Derrick RobertsonTampa$27.6M
- Beth SafirsteinHallandale Beach$25.7M
- Michael PfefferMiami$24.5M
- Mark BrodyDelray Beach$20.5M
- Paayal PatelWest Palm Beach$17.3M
- Wendy BondFort Myers$14.7M
- William HoneycuttMaitland$14.1M
- Julie SchwartzbardAventura$13.6M
- Rekha GandhiWinter Park$13.4M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.